1. Ostrom QT, Gittleman H, Liao P, et al. (2017) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014. Neuro Oncol, 19(5): v1-v88. [ DOI:10.1093/neuonc/nox158] [ PMID] [ ] 2. Stupp R, Mason WP, Van Den Bent MJ, et al. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med, 352(10): 987-96. [ DOI:10.1056/NEJMoa043330] [ PMID] 3. Chen L, Guerrero-Cazares H, Ye X, et al. (2013) Increased subventricular zone radiation dose correlates with survival in glioblastoma patients after gross total resection. Int J Radiat Oncol Biol Phys, 86(4): 616-22. [ DOI:10.1016/j.ijrobp.2013.02.014] [ PMID] [ ] 4. Oppitz, U, Maessen, D, Zunterer, H, et al. (1999) 3D-recurrence-patterns of gliobastomas after CT-planned postoperative irradiation. Radiother Oncol, 53(1): 53-7. [ DOI:10.1016/S0167-8140(99)00117-6] 5. Stupp R, Hegi ME, Mason WP, et al. (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol, 10(5): 459-66. [ DOI:10.1016/S1470-2045(09)70025-7] 6. Diksin M, Smith SJ, Rahman R (2017) The molecular and phenotypic basis of the glioma invasive perivascular niche. Int J Mol Sci, 18(11): 2342. [ DOI:10.3390/ijms18112342] [ PMID] [ ] 7. Trone J-C, Vallard A, Sotton S, et al. (2020) Survival after hypofractionation in glioblastoma: a systematic review and meta-analysis. Radiation Oncology, 15: 1-10. [ DOI:10.1186/s13014-020-01584-6] [ PMID] [ ] 8. Bloch O, Han SJ, Cha S, et al. (2012) Impact of extent of resection for recurrent glioblastoma on overall survival. J Neurosurg Sci, 117(6): 1032-8. [ DOI:10.3171/2012.9.JNS12504] [ PMID] 9. Scoccianti S, Perna M, Olmetto E, et al. (2020) Local treatment for relapsing glioblastoma: A decision-making tree for choosing between reirradiation and second surgery. Critical Reviews in Oncology/Hematology, 2020: 103184. [ DOI:10.1016/j.critrevonc.2020.103184] [ PMID] 10. Combs SE, Widmer V, Thilmann C, et al. (2005) Stereotactic radiosurgery (SRS) treatment option for recurrent glioblastoma multiforme (GBM). Cancer, 104(10): 2168-73. [ DOI:10.1002/cncr.21429] [ PMID] 11. Reynaud T, Bertaut A, Farah W, et al. (2018) Hypofractionated stereotactic radiotherapy as a salvage therapy for recurrent high-grade gliomas: Single-center experience. Technol Cancer Res Treat, 17: 1533033818806498. [ DOI:10.1177/1533033818806498] [ PMID] [ ] 12. Eren G, Zorlu F, Yazici G, et al. (2021) Stereotactic radiosurgery and fractionated stereotactic radiosurgery in patients with recurrent glial tumors. Int J Hemato Oncol, 31(4): 255-63. 13. Gutin PH, Iwamoto FM, Beal K, et al. (2009) Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas. Int J Radiat Oncol Biol Phys, 75(1): 156-63. [ DOI:10.1016/j.ijrobp.2008.10.043] [ PMID] [ ] 14. Fogh SE, Andrews DW, Glass J, et al. (2010) Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas. J Clin Oncol, 28(18): 3048. [ DOI:10.1200/JCO.2009.25.6941] [ PMID] [ ] 15. Tsien C, Pugh S, Dicker A, et al. (2019) Randomized phase II trial of re-irradiation and concurrent bevacizumab versus bevacizumab alone as treatment for recurrent glioblastoma (NRG Oncology/RTOG 1205): initial outcomes and rt plan quality report. Oral Scientific Session, 105(1): S78. [ DOI:10.1016/j.ijrobp.2019.06.539] 16. Pirzkall A, McKnight TR, Graves EE, et al. (2001) MR-spectroscopy guided target delineation for high-grade gliomas. Int J Radiat Oncol Biol Phys, 50(4): 915-28. [ DOI:10.1016/S0360-3016(01)01548-6] 17. Wen PY, Macdonald DR, Reardon DA, et al. (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol, 28(11): 1963-72. [ DOI:10.1200/JCO.2009.26.3541] [ PMID] 18. Atkinson TM, Ryan SJ, Bennett AV, et al. (2016) The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review. Support Care Cancer, 24(8): 3669-76. [ DOI:10.1007/s00520-016-3297-9] [ PMID] [ ] 19. Kaplan EL and Meier P (1958) Nonparametric estimation from incomplete observations. Journal of the American statistical association. J American Statistical Association 53(282): 457-81. [ DOI:10.1080/01621459.1958.10501452] 20. Сох D (1972) Regression models and life-tables. Journal of the Royal Statistical Society. Series B, 34(2): 187-220. [ DOI:10.1111/j.2517-6161.1972.tb00899.x] 21. Shaw E, Scott C, Souhami L, et al. (2000) Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Physics, 47(2): 291-8. [ DOI:10.1016/S0360-3016(99)00507-6] 22. Dirks P, Bernstein M, Muller P, et al. (1993) The value of reoperation for recurrent glioblastoma. Canadian journal of surgery, 36(3): 271-5. 23. Oppenlander ME, Wolf AB, Snyder LA, et al. (2014) An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity. Journal of Neurosugery, 120(4): 846-53. [ DOI:10.3171/2013.12.JNS13184] [ PMID] 24. Scoccianti S, Francolini G, Carta GA, et al. (2018) Re-irradiation as salvage treatment in recurrent glioblastoma: a comprehensive literature review to provide practical answers to frequently asked questions. Crit Rev Oncol Hematol, 126: 80-91. [ DOI:10.1016/j.critrevonc.2018.03.024] [ PMID] 25. Clarke J, Neil E, Terziev R, et al. (2017) Multicenter, phase 1, dose escalation study of hypofractionated stereotactic radiation therapy with bevacizumab for recurrent glioblastoma and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys , 99(4): 797-804. [ DOI:10.1016/j.ijrobp.2017.06.2466] [ PMID] [ ] 26. Yaprak G, Isık N, Gemici C, et al. (2020) Stereotactic radiotherapy in recurrent glioblastoma: a valid salvage treatment option. Stereotact Funct Neurosurg, 98(3): 167-75. [ DOI:10.1159/000505706] [ PMID] 27. Yazici G, Cengiz M, Ozyigit G, et al. (2014) Hypofractionated stereotactic reirradiation for recurrent glioblastoma. J Neurooncol, 120(1): 117-23. [ DOI:10.1007/s11060-014-1524-0] [ PMID] 28. Kazmi F, Soon YY, Leong YH, et al. (2019) Re-irradiation for recurrent glioblastoma (GBM): a systematic review and meta-analysis. J Neurooncol, 142(1): 79-90. [ DOI:10.1007/s11060-018-03064-0] [ PMID] 29. De Wit M, De Bruin H, Eijkenboom W, et al. (2004) Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression. Neurology, 63(3): 535-7. [ DOI:10.1212/01.WNL.0000133398.11870.9A] [ PMID] 30. Lederman, G, Wronski, M, Arbit, E, et al. (2000) Treatment of recurrent glioblastoma multiforme using fractionated stereotactic radiosurgery and concurrent paclitaxel. Am J Clin Oncol, 23(2): 155-9. [ DOI:10.1097/00000421-200004000-00010] [ PMID] 31. Hudes RS, Corn BW, Werner-Wasik M, et al. (1999) A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma. Int J Radiat Oncol Biol Phys, 43(2): 293-8. [ DOI:10.1016/S0360-3016(98)00416-7] 32. Hasan S, Chen E, Lanciano R, et al. (2015) Salvage fractionated stereotactic radiotherapy with or without chemotherapy and immunotherapy for recurrent glioblastoma multiforme: a single institution experience. Radiation Oncology, 5: 106. [ DOI:10.3389/fonc.2015.00106] [ PMID] [ ] 33. Vordermark D, Kölbl O, Ruprecht K, et al. (2005) Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma. BMC Cancer, 5(1): 1-7. [ DOI:10.1186/1471-2407-5-55] [ PMID] [ ] 34. Voynov G, Kaufman S, Hong T, et al. (2002) Treatment of recurrent malignant gliomas with stereotactic intensity modulated radiation therapy. American J Clinical Oncology, 25(6): 606-11. [ DOI:10.1097/00000421-200212000-00017] [ PMID] 35. Shepherd SF, Laing RW, Cosgrove VP, et al. (1997) Hypofractionated stereotactic radiotherapy in the management of recurrent glioma. Int J Radiat Oncol Biol Phys, 37(2): 393-8. [ DOI:10.1016/S0360-3016(96)00455-5] 36. Ruben JD, Dally M, Bailey M, et al. (2006) Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy. Int J Radiat Oncol Biol Physics, 65(2): 499-508. [ DOI:10.1016/j.ijrobp.2005.12.002] [ PMID] 37. Blonigen BJ, Steinmetz RD, Levin L, et al. (2010) Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery. Int J Radiat Oncol Biol Physics, 77(4): 996-1001. [ DOI:10.1016/j.ijrobp.2009.06.006] [ PMID] 38. Hudes RS, Corn BW, Werner-Wasik M, et al. (1999) A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma. Int J Radiat Oncol Biol Phys, 43(2): 293-8. [ DOI:10.1016/S0360-3016(98)00416-7] 39. Hall WA, Djalilian HR, Sperduto PW, et al. (1995) Stereotactic radiosurgery for recurrent malignant gliomas. Journal of clinical oncology, 13(7): 1642-8. [ DOI:10.1200/JCO.1995.13.7.1642] [ PMID] 40. Pannullo SC, Fraser JF, Moliterno J, et al. (2011) Stereotactic radiosurgery: a meta-analysis of current therapeutic applications in neuro-oncologic disease. Journal of neuro-oncology, 103(1): 1-17. [ DOI:10.1007/s11060-010-0360-0] [ PMID]
|